VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
A phase 2 clinical trial of eltrombopag for treatment of patients with myelodysplastic syndromes after hypomethylating-agent failure.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A phase 2 clinical trial of eltrombopag for treatment of patients with myelodysplastic syndromes after hypomethylating-agent failure.
A phase 2 clinical trial of eltrombopag for treatment of patients with myelodysplastic syndromes after hypomethylating-agent failure. Leuk Lymphoma. 2019 09; 60(9):2207-2213.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Antimetabolites, Antineoplastic
Antineoplastic Combined Chemotherapy Protocols
Benzoates
Blood Platelets
Disease Progression
DNA Methylation
Drug Resistance, Neoplasm
Female
Follow-Up Studies
Humans
Hydrazines
Kaplan-Meier Estimate
Male
Middle Aged
Myelodysplastic Syndromes
Platelet Count
Prognosis
Pyrazoles
Treatment Outcome
authors with profiles
CARLOS E BUESO-RAMOS
MARINA KONOPLEVA
ALESSANDRA FERRAJOLI
GUILLERMO GARCIA-MANERO
JOSEPH KHOURY
YESID ALVARADO
GAUTAM BORTHAKUR
TAPAN MAHENDRA KADIA
NAVEEN PEMMARAJU
COURTNEY DINARDO